Hester Biosciences [HESTERBIO] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Hester Biosciences Ltd.

NSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Hester Biosciences Ltd. wins in 14 metrics, Sun Pharma Advanced Research Company Ltd. wins in 4 metrics, with 0 ties. Hester Biosciences Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Hester Biosciences Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 30.37 -13.65 Hester Biosciences Ltd.
Price-to-Book Ratio 3.73 -13.55 Hester Biosciences Ltd.
Debt-to-Equity Ratio 60.85 -1.21 Hester Biosciences Ltd.
PEG Ratio -1.65 -11.15 Hester Biosciences Ltd.
EV/EBITDA 19.66 -22.27 Hester Biosciences Ltd.
Profit Margin (TTM) 12.97% -53.22% Hester Biosciences Ltd.
Operating Margin (TTM) 17.26% -700.71% Hester Biosciences Ltd.
EBITDA Margin (TTM) 17.26% N/A N/A
Return on Equity 8.41% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 4.21% -102.08% Hester Biosciences Ltd.
Free Cash Flow (TTM) $439.20M $-3.71B Hester Biosciences Ltd.
Dividend Yield 0.64% N/A N/A
1-Year Return 5.05% 34.88% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 3.96 87.98 Hester Biosciences Ltd.
Enterprise Value $14.12B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 4.47 95.73 Hester Biosciences Ltd.
Gross Profit Margin (TTM) 73.22% -59.53% Hester Biosciences Ltd.
Revenue per Share (TTM) $369 $2 Hester Biosciences Ltd.
Earnings per Share (Diluted) $48.41 $-8.25 Hester Biosciences Ltd.
Beta (Stock Volatility) 0.22 0.19 Sun Pharma Advanced Research Company Ltd.

Hester Biosciences Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

HESTERBIO
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hester Biosciences Ltd.5.82%5.27%12.84%43.52%29.64%29.64%
Sun Pharma Advanced Research Company Ltd.2.36%12.49%39.95%100.62%67.89%69.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hester Biosciences Ltd.5.05%19.30%-22.79%198.65%322.75%322.75%
Sun Pharma Advanced Research Company Ltd.34.88%14.54%-3.55%-20.47%148.26%-23.02%

Performance & Financial Health Analysis: Hester Biosciences Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricHESTERBIOSPARC
Market Information
Market Cap i₹12.57B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i3,3412,401,062
90 Day Avg. Volume i4,9442,083,443
Last Close₹2,066.60₹229.03
52 Week Range₹1,239.30 - ₹2,350.00₹108.00 - ₹248.75
% from 52W High-12.06%-7.93%
All-Time High₹3,379.00 (Jul 22, 2024)₹875.00 (Apr 24, 2006)
% from All-Time High-38.84%-73.83%
Growth Metrics
Quarterly Revenue Growth0.09%-0.43%
Quarterly Earnings Growth-0.25%-0.43%
Financial Health
Profit Margin (TTM) i0.13%-0.53%
Operating Margin (TTM) i0.17%-7.01%
Return on Equity (TTM) i0.08%1.58%
Debt to Equity (MRQ) i60.85-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹394.06₹-10.63
Cash per Share (MRQ)₹9.91₹0.03
Operating Cash Flow (TTM) i₹554.94M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹274.88M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i0.64%N/A
Last 12-Month Dividend i₹13.00N/A

Valuation & Enterprise Metrics Analysis: Hester Biosciences Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricHESTERBIO (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i30.37-13.65
Forward P/E iN/A2.60
PEG Ratio i-1.65-11.15
Price to Sales (TTM) i3.9687.98
Price to Book (MRQ) i3.73-13.55
Market Capitalization
Market Capitalization i₹12.57B₹46.75B
Enterprise Value i₹14.12B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i4.4795.73
Enterprise to EBITDA i19.66-22.27
Risk & Other Metrics
Beta i0.220.19
Book Value per Share (MRQ) i₹394.06₹-10.63

Financial Statements Comparison: Hester Biosciences Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHESTERBIO (2025)SPARC (2025)
Revenue/Sales i3.11B717.66M
Cost of Goods Sold i1.03B1.10B
COGS % of Revenue i33.0%153.2%
Gross Profit i2.08B-381.94M
Gross Margin i67.0%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i452.43M-3.34B
Operating Margin i14.5%-465.5%
EBITDA i651.99M-3.23B
EBITDA Margin i21.0%-450.0%
Pre-Tax Income i395.71M-3.43B
Pre-Tax Income % of Revenue i12.7%-477.6%
Income Tax i107.45M-2.72M
Income Tax % of Revenue i3.5%-0.4%
Net Income (Profit) i288.26M-3.43B
Profit Margin i9.3%-477.3%

Balance Sheet & Liquidity Metrics

MetricHESTERBIO (2025)SPARC (2025)
Cash & Equivalents i55.87M19.64M
Total Current Assets i1.95B261.97M
Total Current Assets % of Revenue i62.7%36.5%
Total Current Liabilities i1.25B3.74B
Total Current Liabilities % of Revenue i40.2%521.5%
Long-Term Debt i1.39B1.07B
Long-Term Debt % of Revenue i44.6%149.0%
Total Shareholders Equity i3.27B-2.17B
Retained Earnings i2.37B-23.22B
Retained Earnings % of Revenue i76.2%-3,235.0%
Property, Plant & Equipment i59.22M178.02M

Cash Flow Statement Comparison

MetricHESTERBIO (2025)SPARC (2025)
Operating Cash Flow i554.94M-3.48B
Operating Cash Flow % of Revenue i17.8%-485.5%
Capital Expenditures i2.74M-97.45M
Free Cash Flow i439.20M-3.71B
FCF Margin i14.1%-516.4%
Debt Repayment i-331.16M-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricHESTERBIOSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i8.51M324.52M
Float Shares i2.50M91.32M
% Held by Insiders i68.79%72.96%
% Held by Institutions i0.37%2.56%
% Held by Public i30.84%24.48%

Dividend Analysis & Yield Comparison: Hester Biosciences Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricHESTERBIOSPARC
Last 12-Month Dividend i₹13.00N/A
Last 12-Month Dividend Yield i0.64%N/A
3-Year Avg Annual Dividend i₹10.33N/A
3-Year Avg Dividend Yield i0.37%N/A
3-Year Total Dividends i₹31.00N/A
Ex-Dividend DateAug 06, 2025N/A